As of 2025-07-19, the Relative Valuation of Pfizer Inc (PFE) is 27.92 USD. This relative valuation is based on P/E multiples. With the latest stock price at 24.47 USD, the upside of Pfizer Inc based on Relative Valuation is 14.1%.
The range of the Relative Valuation is 23.61 - 38.52 USD.
| Range | Selected | |
| Trailing P/E multiples | 17.7x - 27.8x | 22.0x |
| Forward P/E multiples | 18.9x - 21.8x | 20.2x |
| Fair Price | 23.61 - 38.52 | 27.92 |
| Upside | -3.5% - 57.4% | 14.1% |
| Date | P/E |
| 2025-07-18 | 17.65 |
| 2025-07-17 | 17.73 |
| 2025-07-16 | 17.75 |
| 2025-07-15 | 17.75 |
| 2025-07-14 | 18.28 |
| 2025-07-11 | 18.50 |
| 2025-07-10 | 18.59 |
| 2025-07-09 | 18.43 |
| 2025-07-08 | 18.48 |
| 2025-07-07 | 18.20 |
| 2025-07-03 | 18.30 |
| 2025-07-02 | 18.26 |
| 2025-07-01 | 18.06 |
| 2025-06-30 | 17.48 |
| 2025-06-27 | 17.44 |
| 2025-06-26 | 17.48 |
| 2025-06-25 | 17.49 |
| 2025-06-24 | 17.53 |
| 2025-06-23 | 17.33 |
| 2025-06-20 | 17.29 |
| 2025-06-18 | 17.22 |
| 2025-06-17 | 17.31 |
| 2025-06-16 | 17.60 |
| 2025-06-13 | 17.70 |
| 2025-06-12 | 17.91 |
| 2025-06-11 | 17.65 |
| 2025-06-10 | 17.52 |
| 2025-06-09 | 17.29 |
| 2025-06-06 | 16.84 |
| 2025-06-05 | 16.67 |
| 2025-06-04 | 16.87 |
| 2025-06-03 | 16.84 |
| 2025-06-02 | 16.92 |
| 2025-05-30 | 16.94 |
| 2025-05-29 | 16.91 |
| 2025-05-28 | 16.72 |
| 2025-05-27 | 17.03 |
| 2025-05-23 | 16.82 |
| 2025-05-22 | 16.61 |
| 2025-05-21 | 16.61 |
| 2025-05-20 | 16.96 |
| 2025-05-19 | 16.59 |
| 2025-05-16 | 16.46 |
| 2025-05-15 | 16.30 |
| 2025-05-14 | 15.88 |
| 2025-05-13 | 16.49 |
| 2025-05-12 | 16.65 |
| 2025-05-09 | 16.07 |
| 2025-05-08 | 16.56 |
| 2025-05-07 | 16.43 |